The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Abstract
The innate immune system senses viral infection by recognizing a variety of viral components (including double-stranded (ds)RNA) and triggers antiviral responses. The cytoplasmic helicase proteins RIG-I (retinoic-acid-inducible protein I, also known as Ddx58) and MDA5 (melanoma-differentiation-associated gene 5, also known as Ifih1 or Helicard) have been implicated in viral dsRNA recognition. In vitro studies suggest that both RIG-I and MDA5 detect RNA viruses and polyinosine-polycytidylic acid (poly(I:C)), a synthetic dsRNA analogue. Although a critical role for RIG-I in the recognition of several RNA viruses has been clarified, the functional role of MDA5 and the relationship between these dsRNA detectors in vivo are yet to be determined. Here we use mice deficient in MDA5 (MDA5-/-) to show that MDA5 and RIG-I recognize different types of dsRNAs: MDA5 recognizes poly(I:C), and RIG-I detects in vitro transcribed dsRNAs. RNA viruses are also differentially recognized by RIG-I and MDA5. We find that RIG-I is essential for the production of interferons in response to RNA viruses including paramyxoviruses, influenza virus and Japanese encephalitis virus, whereas MDA5 is critical for picornavirus detection. Furthermore, RIG-I-/- and MDA5-/- mice are highly susceptible to infection with these respective RNA viruses compared to control mice. Together, our data show that RIG-I and MDA5 distinguish different RNA viruses and are critical for host antiviral responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, several RNA structural features have been described as immunostimulatory due to interactions with various RNA sensors such as Toll-like receptors, RIG-I, and PKR.”
From Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals (2015) · cites this paper as [11]
Citations
Cites
Pathogen Recognition and Innate Immunity
Akira, S., Uematsu, S., & Takeuchi, O. (2006) · Cell · doi:10.1016/j.cell.2006.02.015 · Cited by 11,976
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
Toll-like receptor control of the adaptive immune responses
Iwasaki, A., & Medzhitov, R. M. (2004) · Nature Immunology · doi:10.1038/ni1112 · Cited by 4,166
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 4,022
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway
Yamamoto, M., Sato, S., Hemmi, H., Hoshino, K., Kaisho, T., Sanjo, H., Takeuchi, O., Sugiyama, M., Okabe, M., Takeda, K., et al. (2003) · Science · doi:10.1126/science.1087262 · Cited by 3,286
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,680
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Self-citationCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,007
Wies, E., Wang, M. K., Maharaj, N. P., Chen, K., Zhou, S., Finberg, R. W., & Gack, M. U. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.018 · Cited by 316
Toll-Like Receptor Agonists in Cancer Therapy
Adams, S. (2009) · Immunotherapy · doi:10.2217/imt.09.70 · Cited by 311
Koyama, S., Ishii, K. J., Kumar, H., Tanimoto, T., Coban, C., Uematsu, S., Kawai, T., & Akira, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4711 · Cited by 315
Hall, J. C., Casciola-Rosen, L. A., Samedy-Bates, L.-A., Werner, J. L., Owoyemi, K., Danoff, S. K., & Christopher‐Stine, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21992 · Cited by 306
Mukherjee, A., Morosky, S. A., Delorme‐Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., & Coyne, C. B. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001311 · Cited by 316
TRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway
Michallet, M., Meylan, E., Ermolaeva, M., Vázquez, J., Rebsamen, M., Curran, J. A., Poeck, H., Bscheider, M., Hartmann, G., König, M. F., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.013 · Cited by 304
An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction
Xia, H., Luo, H., Shan, C., Muruato, A. E., Nunes, B. T. D., Medeiros, D. B. D. A., Zou, J., Xie, X., Giraldo, M. I., Vasconcelos, P. F. D. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02816-2 · Cited by 316
Miyashita, M., Oshiumi, H., Matsumoto, M., & Seya, T. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01368-10 · Cited by 297
Recognition of viral nucleic acids in innate immunity
Yoneyama, M., & Fujita, T. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.633 · Cited by 313
Regulation of immunity and oncogenesis by the IRF transcription factor family
Savitsky, D., Tamura, T., Yanai, H., & Taniguchi, T. (2010) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-009-0804-6 · Cited by 298
Österlund, P., Pietilä, T. E., Veckman, V., Kotenko, S. V., & Julkunen, I. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3434 · Cited by 301
mda-5, but not RIG-I, is a common target for paramyxovirus V proteins
Childs, K., Stock, N., Ross, C., Andrejeva, J., Hilton, L. S., Skinner, M. A., Randall, R. E., & Goodbourn, S. (2006) · Virology · doi:10.1016/j.virol.2006.09.023 · Cited by 299
RNA- and Virus-Independent Inhibition of Antiviral Signaling by RNA Helicase LGP2
Komuro, A., & Horvath, C. M. (2006) · Journal of Virology · doi:10.1128/jvi.01325-06 · Cited by 298
Targeting the DNA damage response in immuno-oncology: developments and opportunities
Chabanon, R. M., Rouanne, M., Lord, C. J., Soria, J., Pasero, P., & Postel-Vinay, S. C. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00386-6 · Cited by 306
Foxman, E. F., Storer, J. A., Fitzgerald, M. E., Wasik, B. R., Hou, L., Zhao, H., Turner, P. E., Pyle, A. M., & Iwasaki, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411030112 · Cited by 302
McWhirter, S. M., Barbalat, R., Monroe, K. M., Fontana, M. F., Hyodo, M., Joncker, N. T., Ishii, K. J., Akira, S., Colonna, M., Chen, Z. J., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20082874 · Cited by 301
Lei, Y. L., Wen, H., Yu, Y., Taxman, D. J., Zhang, L., Widman, D. G., Swanson, K. V., Wen, K. W., Damania, B., Moore, C., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.025 · Cited by 297
The function and clinical application of extracellular vesicles in innate immune regulation
Zhou, X., Xie, F., Wang, L., Zhang, L., Zhang, S., Fang, M., & Zhou, F. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0391-1 · Cited by 294
Hu, Y., Li, W., Gao, T., Cui, Y., Jin, Y., Li, P., Ma, Q., Liu, X. E., & Cao, C. (2017) · Journal of Virology · doi:10.1128/jvi.02143-16 · Cited by 294
RNA helicases — one fold for many functions
Jankowsky, E., & Fairman, M. E. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.05.007 · Cited by 290
Coronavirus endoribonuclease targets viral polyuridine sequences to evade activating host sensors
Hackbart, M., Deng, X., & Baker, S. C. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921485117 · Cited by 289
Boonstra, A., Rajsbaum, R., Holman, M. J., Marques, R., Asselin‐Paturel, C., Pereira, J. P., Bates, E. E. M., Akira, S., Vieira, P., Liu, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7551 · Cited by 288
Ye, X., Zhou, S., & Zhang, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02334 · Cited by 299
NS1 Protein of Influenza A Virus Inhibits the Function of Intracytoplasmic Pathogen Sensor, RIG-I
Guo, Z., Chen, L.-M., Zeng, H., Gomez, J. A., Plowden, J., Fujita, T., Katz, J. M., Donis, R. O., & Sambhara, S. R. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0283rc · Cited by 286
Influenza virus targets the mRNA export machinery and the nuclear pore complex
Satterly, N., Tsai, P.-L., van Deursen, J., Nussenzveig, D. R., Wang, Y., Waziry, P. A. F., Levay, A. K., Levy, D. E., & Fontoura, B. M. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610977104 · Cited by 288
How the Noninflammasome NLRs Function in the Innate Immune System
Ting, J. P. ‐., Duncan, J. A., & Lei, Y. L. (2010) · Science · doi:10.1126/science.1184004 · Cited by 288
Adjuvants: Classification, Modus Operandi , and Licensing
Apostólico, J. D. S., Lunardelli, V. A. S., Coirada, F. C., Boscardin, S. B., & Rosa, D. S. (2016) · Journal of Immunology Research · doi:10.1155/2016/1459394 · Cited by 303
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A. D., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 281
IFN? induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein
Opitz, B., Rejaibi, A., Dauber, B., Eckhard, J., Vinzing, M., Schmeck, B., Hippenstiel, S., Suttorp, N., & Wolff, T. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00841.x · Cited by 281
The Control of Adaptive Immune Responses by the Innate Immune System
Schenten, D., & Medzhitov, R. M. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387664-5.00003-0 · Cited by 290
Casadio, M., Ciancanelli, M. J., Ou, Y.-H., Lorenzo, L., Klaudel‐Dreszler, M., Pauwels, E., Sancho‐Shimizu, V., de Diego, R. P., Abhyankar, A., Israelsson, E., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111316 · Cited by 292
Viral apoptosis is induced by IRF‐3‐mediated activation of Bax
Chattopadhyay, S., Marques, J. T., Yamashita, M., Peters, K. L., Smith, K., Desai, A., Williams, B. R. G., & Sen, G. C. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.50 · Cited by 281
Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells
Sato, A., Linehan, M. M., & Iwasaki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605102103 · Cited by 278
Paun, A., & Pitha, P. M. (2007) · Biochimie · doi:10.1016/j.biochi.2007.01.014 · Cited by 277
Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung
Opitz, B., van Laak, V., Eitel, J., & Suttorp, N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1427so · Cited by 287
Antiviral Activity of Human OASL Protein Is Mediated by Enhancing Signaling of the RIG-I RNA Sensor
Zhu, J., Zhang, Y., Ghosh, A., Cuevas, R. A., Forero, A., Dhar, J., Ibsen, M. S., Schmid-Burgk, J. L., Schmidt, T., Ganapathiraju, M. K., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.05.007 · Cited by 274
Barnett, K. C., Coronas-Serna, J. M., Zhou, W., Ernandes, M. J., Cao, A., Kranzusch, P. J., & Kagan, J. C. (2019) · Cell · doi:10.1016/j.cell.2019.01.049 · Cited by 275
Beura, L. K., Sarkar, S. N., Kwon, B., Subramaniam, S., Jones, C., Pattnaik, A. K., & Osorio, F. A. (2009) · Journal of Virology · doi:10.1128/jvi.01326-09 · Cited by 271
Bruns, A. M., Leser, G. P., Lamb, R. A., & Horvath, C. M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.07.003 · Cited by 262
Innate immune evasion strategies of DNA and RNA viruses
Beachboard, D. C., & Horner, S. M. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.015 · Cited by 268
Structural Mechanism of RNA Recognition by the RIG-I-like Receptors
Yoneyama, M., & Fujita, T. (2008) · Immunity · doi:10.1016/j.immuni.2008.07.009 · Cited by 266
The response of mammalian cells to double-stranded RNA
Gantier, M. P., & Williams, B. R. G. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.016 · Cited by 273
Type I interferons: crucial participants in disease amplification in autoimmunity
Hall, J. C., & Rosen, A. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.237 · Cited by 268
Autoimmune Disorders Associated with Gain of Function of the Intracellular Sensor MDA5
Funabiki, M., Kato, H., Miyachi, Y., Toki, H., Motegi, H., Inoue, M., Minowa, O., Yoshida, A., Deguchi, K., Satō, H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.014 · Cited by 262
Oshiumi, H., Miyashita, M., Inoue, N., Okabe, M., Matsumoto, M., & Seya, T. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.11.008 · Cited by 264
Wu, J., Shi, Y., Pan, X., Wu, S., Hou, R., Zhang, Y., Zhong, T., Tang, H., Du, W., Wang, L., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108761 · Cited by 278
Aspects of Genetic Susceptibility to Human Infectious Diseases
Hill, A. V. S. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.40.110405.090546 · Cited by 267
Positive Regulation of Interferon Regulatory Factor 3 Activation by Herc5 via ISG15 Modification
Shi, H.-X., Yang, K. S., Liu, X., Liu, X.-Y., Wei, B., Shan, Y.-F., Zhu, L.-H., & Wang, C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01466-09 · Cited by 265
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 276
The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune ResponsesPreprint
Ikushima, H., Negishi, H., & Taniguchi, T. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020321 · Cited by 273
Yajima, T., & Knowlton, K. U. (2009) · Circulation · doi:10.1161/circulationaha.108.766022 · Cited by 266
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Lara D. Veeken · doi:10.1093/rheumatology/keq153 · Cited by 261
Regulation of NF‐κB by deubiquitinases
Harhaj, E. W., & Dixit, V. M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01100.x · Cited by 266
Mitochondrial Membrane Potential Is Required for MAVS-Mediated Antiviral Signaling
Koshiba, T., Yasukawa, K., Yanagi, Y., & Kawabata, S.-I. (2011) · Science Signaling · doi:10.1126/scisignal.2001147 · Cited by 257
Biacchesi, S., Berre, M. L., Lamoureux, A., Louise, Y., Lauret, É., Boudinot, P., & Brémont, M. (2009) · Journal of Virology · doi:10.1128/jvi.00404-09 · Cited by 258
Innate immunity, macrophage activation, and atherosclerosis
Yan, Z., & Hansson, G. K. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00554.x · Cited by 258
Chang, M., Jin, W., & Sun, S. (2009) · Nature Immunology · doi:10.1038/ni.1777 · Cited by 259
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
Yasukawa, K., Oshiumi, H., Takeda, M., Ishihara, N., Yanagi, Y., Seya, T., Kawabata, S.-I., & Koshiba, T. (2009) · Science Signaling · doi:10.1126/scisignal.2000287 · Cited by 255
Origin and evolution of the RIG-I like RNA helicase gene family
Zou, J., Chang, M., Nie, P., & Secombes, C. J. (2009) · BMC Evolutionary Biology · doi:10.1186/1471-2148-9-85 · Cited by 257
Immunity to Respiratory Viruses
Kohlmeier, J. E., & Woodland, D. L. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132625 · Cited by 262
MDA5 Detects the Double-Stranded RNA Replicative Form in Picornavirus-Infected Cells
Feng, Q., Hato, S. V., Langereis, M. A., Zoll, J., Virgen‐Slane, R., Peisley, A., Hur, S., Semler, B. L., van Rij, R. P., & van Kuppeveld, F. J. M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.005 · Cited by 254
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
Sajid, M. I., Moazzam, M., Kato, S., Cho, K. Y., & Tiwari, R. K. (2020) · Pharmaceuticals · doi:10.3390/ph13100294 · Cited by 262
Toll‐like receptors, RIG‐I‐like RNA helicases and the antiviral innate immune response
Thompson, A. J. V., & LOCARNINI, S. A. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100100 · Cited by 260
An, H., Hou, J., Zhou, J., Zhao, W., Xu, H., Zheng, Y., Yu, Y., Liu, S., & Cao, X. (2008) · Nature Immunology · doi:10.1038/ni.1604 · Cited by 250
Peste Des Petits Ruminants Virus Infection of Small Ruminants: A Comprehensive Review
Kumar, N., Maherchandani, S., Kashyap, S. K., Singh, S. V., Sharma, S., Chaubey, K. K., & Ly, H. (2014) · Viruses · doi:10.3390/v6062287 · Cited by 249
Yamada, T., Horimoto, H., Kameyama, T., Hayakawa, S., Yamato, H., Dazai, M., Takada, A., Kida, H., Bott, D., Zhou, A. C., et al. (2016) · Nature Immunology · doi:10.1038/ni.3422 · Cited by 251
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
Hafner, A. M., Corthésy, B., & Merkle, H. P. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.05.013 · Cited by 254
Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses
Hiscott, J. B., Nguyen, T.-L. A., Argüello, M., Nakhaei, P., & Paz, S. (2006) · Oncogene · doi:10.1038/sj.onc.1209941 · Cited by 251
RIP kinases: key decision makers in cell death and innate immunity
Humphries, F., Yang, S., Wang, B., & Moynagh, P. N. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.126 · Cited by 249
Varga, Z. T., Ramos, I., Hai, R., Schmolke, M., García‐Sastre, A., Fernández-Sesma, A., & Palese, P. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002067 · Cited by 246
The molecular mechanism of RIG‐I activation and signaling
Thoresen, D., Wang, W., Galls, D., Guo, R., Xu, L., & Pyle, A. M. (2021) · Immunological Reviews · doi:10.1111/imr.13022 · Cited by 243
Cytoplasmic DNA innate immune pathways
Barber, G. N. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01051.x · Cited by 254
Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens
Newman, K. C., & Riley, E. M. (2007) · Nature reviews. Immunology · doi:10.1038/nri2057 · Cited by 245
Zhang, Z., Bao, M., Lu, N., Weng, L., Yuan, B., & Liu, Y. (2012) · Nature Immunology · doi:10.1038/ni.2492 · Cited by 249
How RIG-I like receptors activate MAVS
Wu, B., & Hur, S. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.04.004 · Cited by 242
Expanding role of ubiquitination in NF-κB signaling
Liu, S., & Chen, Z. J. (2010) · Cell Research · doi:10.1038/cr.2010.170 · Cited by 243
Duffy, D., Rouilly, V., Libri, V., Hasan, M., Beitz, B., David, M., Urrutia, A., Bisiaux, A., LaBrie, S. T., Dubois, A., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.002 · Cited by 242
Evasion of Influenza A Viruses from Innate and Adaptive Immune Responses
van de Sandt, C. E., Kreijtz, J. H. C. M., & Rimmelzwaan, G. F. (2012) · Viruses · doi:10.3390/v4091438 · Cited by 267
Wang, Q. A., Nagarkar, D. R., Bowman, E., Schneider, D., Gosangi, B., Lei, J., Zhao, Y., McHenry, C. L., Burgens, R. V., Miller, D. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901386 · Cited by 244
Prins, K. C., Cardenas, W. B., & Basler, C. F. (2009) · Journal of Virology · doi:10.1128/jvi.01875-08 · Cited by 238
Pathogen recognition by innate immunity and its signaling
AKIRA, S. (2009) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.85.143 · Cited by 240
Self-citationHartman, Z. C., Appledorn, D. M., & Amalfitano, A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.10.005 · Cited by 239
Convergence of the NF-κB and IRF pathways in the regulation of the innate antiviral response
Hiscott, J. B. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.002 · Cited by 239
Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection
Orzalli, M. H., & Kagan, J. C. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2017.05.007 · Cited by 241
Sweeten PAMPs: Role of sugar complexed PAMPs in innate immunity and vaccine biology
Mahla, R. S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00248 · Cited by 239
Kim, M.-J., Hwang, S., Imaizumi, T., & Yoo, J.-Y. (2007) · Journal of Virology · doi:10.1128/jvi.01650-07 · Cited by 239
The role of airway epithelial cells and innate immune cells in chronic respiratory disease
Holtzman, M. J., Byers, D. E., Alexander‐Brett, J. M., & Wang, X. (2014) · Nature reviews. Immunology · doi:10.1038/nri3739 · Cited by 246
Pathogen recognition by innate receptors
Kumagai, Y., Takeuchi, O., & Akira, S. (2008) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-008-0596-1 · Cited by 241
Saitoh, T., Satoh, T., Yamamoto, N., Uematsu, S., Takeuchi, O., Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.010 · Cited by 237
Lu, X., Pan, J., Tao, J., & Guo, D. (2010) · Virus Genes · doi:10.1007/s11262-010-0544-x · Cited by 235
Induction and evasion of type I interferon responses by influenza viruses
García‐Sastre, A. (2011) · Virus Research · doi:10.1016/j.virusres.2011.10.017 · Cited by 235
Ral GTPases and cancer: linchpin support of the tumorigenic platform
Bodemann, B. O., & White, M. A. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2296 · Cited by 231
The Structural Basis of 5′ Triphosphate Double-Stranded RNA Recognition by RIG-I C-Terminal Domain
Lu, C. C., Xu, H., Ranjith-Kumar, C. T., Brooks, M. T., Hou, T. Y., Hu, F., Herr, A. B., Strong, R. K., Kao, C. C., & Li, P. (2010) · Structure · doi:10.1016/j.str.2010.05.007 · Cited by 233
Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses
Holm, C. K., Rahbek, S. H., Gad, H. H., Bak, R. O., Jakobsen, M. R., Jiang, Z., Hansen, A. L., Jensen, S. K., Sun, C., Thomsen, M. K., et al. (2016) · Nature Communications · doi:10.1038/ncomms10680 · Cited by 241
Mitochondrial DNA-triggered innate immune response: mechanisms and diseases
Hu, M.-M., & Shu, H. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01086-x · Cited by 263
Coxsackievirus B3 Replication and Pathogenesis
Garmaroudi, F. S., Marchant, D., Hendry, R. G., Luo, H., Yang, D., Ye, X., Shi, J., & McManus, B. M. (2015) · Future Microbiology · doi:10.2217/fmb.15.5 · Cited by 232
Vaccine adjuvants as potential cancer immunotherapeutics
Temizoz, B., Kuroda, E., & Ishii, K. J. (2016) · International Immunology · doi:10.1093/intimm/dxw015 · Cited by 236
Epithelial cells and airway diseases
Proud, D., & Leigh, R. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01033.x · Cited by 237
MDA-5 Recognition of a Murine Norovirus
McCartney, S. A., Thackray, L. B., Gitlin, L., Gilfillan, S., Virgin, H. W., & Colonna, M. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000108 · Cited by 224
Roth-Cross, J. K., Bender, S. J., & Weiss, S. R. (2008) · Journal of Virology · doi:10.1128/jvi.01199-08 · Cited by 228
Metadata
- Authors
- Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., Yamaguchi, O., Otsu, K., Tsujimura, T., Koh, C.-S., Reis e Sousa, C., Matsuura, Y., Fujita, T., & Akira, S.
- Affiliations
- Research Institute for Microbial Diseases, The University of Osaka (JP)
- Japan Science and Technology Agency (JP)
- Kyoto University (JP)
- The University of Osaka (JP)
- Hyogo Medical University (JP)
- Shinshu University (JP)
- Corresponding author
- Akira, Shizuo
- ORCID
- Venue
- Nature
- Published
- 2006-04-09
- Volume
- 441
- Issue
- 7089
- Pages
- 101-105
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2028575270
- Cited by
- 3,888
- References
- 28
- Citations by year
- 2026: 143 · 2025: 156 · 2024: 146 · 2023: 163 · 2022: 176 · 2021: 204 · 2020: 182 · 2019: 169 · 2018: 169 · 2017: 175 · 2016: 169 · 2015: 182 · 2014: 233 · 2013: 218 · 2012: 236
- FWCI
- 88.17
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- MDA5, RIG-I, double-stranded RNA recognition, antiviral innate immunity, interferon production, poly(I:C), paramyxovirus, influenza virus, Japanese encephalitis virus, picornavirus, viral susceptibility
- MeSH terms
- DEAD Box Protein 58, Interferon-Induced Helicase, IFIH1, Animals, Encephalitis Virus, Japanese, Encephalomyocarditis virus, Immunity, Innate, RNA Viruses, RNA, Double-Stranded, RNA, Viral, RNA Helicases, Mice, DEAD-box RNA Helicases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review